Pulmonary aspergilloma and AIDS - A comparison of HIV-infected and HIV-negative individuals

被引:58
|
作者
AddrizzoHarris, DJ
Harkin, TJ
McGuinness, G
Naidich, DP
Rom, WN
机构
[1] NYU,MED CTR,DIV PULM & CRIT CARE MED,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT RADIOL,NEW YORK,NY 10016
[3] BELLEVUE HOSP CTR,CHEST SERV,NEW YORK,NY 10016
关键词
AIDS; aspergilloma; hemoptysis;
D O I
10.1378/chest.111.3.612
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective and methods: While pulmonary aspergilloma has been well described in immunocompetent hosts, to date and to our knowledge, there has not been a description of pulmonary aspergilloma in the HIV-infected individual. A retrospective review of cases seen by the Bellevue Hospital Chest Service from January 1992 through June 1995 identified 25 patients with aspergilloma. To investigate the impact of HIV status on pulmonary aspergilloma, we compared clinical presentation, progression of disease, treatment, and outcome in the HIV-infected patient vs the HIV-negative patient with aspergilloma. Results: Of the 25 patients identified, 10 were HIV-infected and 15 were HIV-negative. Predisposing diseases included tuberculosis (18/25, 72%), sarcoidosis (4/25, 16%), and Pneumocystis carinii pneumonia (3/25, 12%). All 25 patients had evidence of aspergilloma on chest CT. In addition, 17 of 25 patients had evidence of Aspergillus species in fungal culture, pathologic specimens, or immunoprecipitins. Hemoptysis was present in 15 of 25 (60%) (11/15 [73%] of the HIV-negative group vs 4/10 [40%] of the HIV-infected group). Severe hemoptysis (>150 mL/d) occurred in 5 of 15 (33%) of the HIV-negative group vs 1 of 10 (10%) of the HIV-infected group. Disease progression occurred more frequently among the HIV-infected group (4/8, 50% vs 1/13, 8% in HIV-negative individuals). All patients with disease progression had lymphocyte subset CD4+ <100 cells per microliter. Four of eight (50%) of the HIV-infected group vs 1 of 13 (8%) of the HIV-negative group died. Summary and conclusions: We conclude the following: (1) although tuberculosis and sarcoidosis are the most prevalent predisposing diseases, P carinii pneumonia in the HIV-infected individual is a risk factor for pulmonary aspergilloma; (2) HIV-infected individuals with CD4+ <100 cells per microliter are more likely to have disease progression despite treatment; and (3) HIV-negative patients are more likely to have hemoptysis requiring intervention.
引用
收藏
页码:612 / 618
页数:7
相关论文
共 50 条
  • [21] HPV Seroconversion Following Anal and Penile HPV Infection in HIV-Negative and HIV-Infected MSM
    Mooij, Sofie H.
    Landen, Olivia
    van der Klis, Fiona R. M.
    van der Sande, Marianne A. B.
    de Melker, Hester E.
    Xiridou, Maria
    van Eeden, Arne
    Heijman, Titia
    Speksnijder, Arjen G. C. L.
    Snijders, Peter J. F.
    van der Loeff, Maarten F. Schim
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11) : 2455 - 2461
  • [22] Low physical function is associated with diabetes mellitus among HIV-infected and HIV-negative men
    Longenberger, A.
    Lim, J.
    Orchard, T. J.
    Brooks, M.
    Brach, J.
    Mertz, K.
    Kingsley, L. A.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A43 - A43
  • [23] Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis
    Dario Cattaneo
    Sara Baldelli
    Andrea Giacomelli
    Davide Minisci
    Paola Meraviglia
    Noemi Astuti
    Marta Fusi
    Valeria Cozzi
    Emilio Clementi
    Massimo Galli
    Cristina Gervasoni
    Clinical Pharmacokinetics, 2019, 58 : 1345 - 1350
  • [24] Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis
    Cattaneo, Dario
    Baldelli, Sara
    Giacomelli, Andrea
    Minisci, Davide
    Meraviglia, Paola
    Astuti, Noemi
    Fusi, Marta
    Cozzi, Valeria
    Clementi, Emilio
    Galli, Massimo
    Gervasoni, Cristina
    CLINICAL PHARMACOKINETICS, 2019, 58 (10) : 1345 - 1350
  • [25] Identifying the appropriate comparison group for HIV-infected individuals
    Wong, Cherise
    Althoff, Keri
    Gange, Stephen J.
    CURRENT OPINION IN HIV AND AIDS, 2014, 9 (04) : 379 - 385
  • [26] Vaccination in HIV-infected individuals
    Le Corre, Nicole
    Autran, Brigitte
    FUTURE VIROLOGY, 2012, 7 (01) : 85 - 102
  • [27] Dyslipidemia in HIV-infected individuals
    Sprinz, Eduardo
    Lazzaretti, Rosmeri Kuhmmer
    Kuhmmer, Regina
    Ribeiro, Jorge Pinto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (06): : 575 - 588
  • [28] Cryptococcosis in HIV-infected individuals
    Adeyemi, OM
    Pulvirenti, J
    Perumal, S
    Mupiddi, U
    Kohl, B
    Jezisek, T
    AIDS, 2004, 18 (16) : 2218 - 2219
  • [29] Increased Rates of Respiratory and Diarrheal Illnesses in HIV-Negative Persons Living With HIV-Infected Individuals in a Densely Populated Urban Slum in Kenya
    Wong, Joshua M.
    Cosmas, Leonard
    Nyachieo, Dhillon
    Williamson, John M.
    Olack, Beatrice
    Okoth, George
    Njuguna, Henry
    Feikin, Daniel R.
    Burke, Heather
    Montgomery, Joel M.
    Breiman, Robert F.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (05): : 745 - 753
  • [30] Higher Proportion of Abnormal Nutritional Status Among Well-Suppressed HIV-Infected Elderly Asians Compared to HIV-Negative Individuals
    Apornpong, Tanakorn
    Han, Win Min
    Chattranukulchai, Pairoj
    Siwamogsatham, Sarawut
    Wattanachanya, Lalita
    Gatechompol, Sivaporn
    Ueaphongsukkit, Thornthun
    Phonphithak, Supalak
    Sakulrak, Salila
    Sangarlangkarn, Aroonsiri
    Kerr, Stephen J.
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (07) : 590 - 596